NCT02609477View on ClinicalTrials.gov

A Study to Evaluate Abuse Potential of Istradefylline

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Drug Abuse
Interventions
DRUG

Istradefylline

Istradefylline 40, 80, 160 mg

DRUG

Phentermine 45 mg

Phentermine 45 or 90 mg

OTHER

Placebo

Placebo

Trial Locations (1)

84106

Pharmaceutical Research Associates, Inc, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

Kyowa Hakko Kirin Pharma, Inc.

INDUSTRY

lead

Kyowa Kirin Co., Ltd.

INDUSTRY